title: Nivolumab Causing a Polymyalgia Rheumatica in a Patient With a Squamous Non-Small Cell Lung Cancer.
abstract: The anti-programmed cell-death-1 antibody, nivolumab, has been recently approved for the treatment of advanced non-small cell lung cancer. Although, today, immune-related adverse effects such as dermatologic, digestive, hepatic, and endocrine toxicities are well-known with immune checkpoint inhibitors, rheumatic diseases are less well described. Herein, we report the case of a patient without a history of arthritis who developed polymyalgia rheumatica after 13 cycles of nivolumab used for the treatment of advanced non-small cell lung cancer. Laboratory evidence of inflammatory syndrome, articular echography, and clinical presentation with classical symptoms and also distal manifestations were suggestive of this chronic inflammatory disorder. Because of a relevant pain, clinicians were forced to suspend immunotherapy. Nevertheless, due to glucocorticoid therapy, the patient's symptoms have decreased progressively. Moreover, nivolumab was reintroduced 8 weeks later, whereas prednisone (10 mg) was continued, without any recurrence symptoms. To conclude, our case suggests that polymyalgia rheumatica might be a very disabling anti-programmed cell-death-1 immune-related adverse effect.
authors.affiliation: Departments of *Pharmacology †Pain and Palliative Care ‡Rheumatology ∥Pneumology, CHU of Caen §Department of General Medicine, Medical School, Normandie University, Caen, France.
authors.forename: Marjorie
authors.initials: M
authors.lastname: Bernier
authors.forename: Cyril
authors.initials: C
authors.lastname: Guillaume
authors.forename: Nathalie
authors.initials: N
authors.lastname: Leon
authors.forename: Joachim
authors.initials: J
authors.lastname: Alexandre
authors.forename: Lea
authors.initials: L
authors.lastname: Hamel-Senecal
authors.forename: Basile
authors.initials: B
authors.lastname: Chretien
authors.forename: Florian
authors.initials: F
authors.lastname: Lecaignec
authors.forename: Xavier
authors.initials: X
authors.lastname: Humbert
authors.forename: Sophie
authors.initials: S
authors.lastname: Fedrizzi
authors.forename: Jeannick
authors.initials: J
authors.lastname: Madelaine
authors.forename: Marion
authors.initials: M
authors.lastname: Sassier